FrancophonIA/ELRC3.0 huggingface dataset:
English: In babies born very prematurely (at or before 28 weeks of gestation) longer gaps than normal between breaths may occur for 2-3 days after vaccination.
Slovenian: Pri zelo nedonošenih dojenčkih (rojenih po 28 tednih gestacije ali prej) se lahko pojavijo daljši premori med vdihi dva do tri dni po cepljenju.
English: What Prevenar looks like and contents of the pack
Slovenian: Izgled cepiva Prevenar in vsebina pakiranja
English: The immunogenicity of Prevenar has been investigated in an open-label, multicenter study in 49 infants with sickle cell disease.
Slovenian: Imunogenost cepiva Prevenar so raziskali v odprti multicentrični študiji pri 49 dojenčkih z anemijo srpastih celic.
English: Additionally, for vaccine serotypes, protection against otitis media is expected to be substantially lower than protection against invasive disease.
Slovenian: Poleg tega je za serotipe, zastopane v cepivu, pričakovati, da bo zaščita pred vnetjem srednjega ušesa znatno manjša kot zaščita pred invazivnimi boleznimi.
English: Detailed information on this product is available on the website of the European Medicines Agency
Slovenian: Podrobne informacije o cepivu so objavljene na spletni strani Evropske agencije za zdravila
English: In the USA, generalised vaccination with Prevenar using a four-dose series in infants and a catch-up programme for children up to 5 years of age was introduced in 2000.
Slovenian: V ZDA so splošno cepljenje s cepivom Prevenar, in sicer zaporedje štirih odmerkov pri dojenčkih in program naknadnega cepljenja za otroke, stare do 5 let, uvedli leta 2000.
English: The immunogenicity of a two-dose primary series in infants plus a booster at about one year of age has been documented in several studies.
Slovenian: Imunogenost primarnega zaporedja dveh odmerkov pri dojenčkih in poživitvenega odmerka približno v starosti enega leta so dokumentirali v več študijah.
English: Prevenar will only protect against ear infections caused by the types of Streptococcus pneumoniae for which the vaccine has been developed.
Slovenian: Prevenar ščiti samo pred okužbami ušesa, ki jih povzročajo tisti tipi bakterije Streptococcus pneumoniae, proti katerim so to cepivo razvili.
English: The need for a booster dose after these immunisation schedules has not been established.
Slovenian: Ali je po teh imunizacijskih shemah potreben poživitveni odmerek, ni bilo ugotovljeno.
English: If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor
Slovenian: Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
English: Inconsistent reduction in response to pertussis antigens as well as to inactivated polio vaccine (IPV) were observed.
Slovenian: Včasih so opazili tudi zmanjšan imunski odgovor na antigene oslovskega kašlja in na inaktivirano polio vakcino (IPV).
English: For any information about this medicinal product, please contact the local representative of the Marketing
Slovenian: Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika
English: Infants aged 2 - 6 months:
Slovenian: Dojenčki od 2. do 6. meseca starosti:
English: Each 0.5 ml dose contains 2 micrograms of saccharide for serotypes 4, 9V, 14, 18C, 19F, and 23F, and 4 micrograms of serotype 6B per dose (16 micrograms total saccharide) conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate (0.5 mg).
Slovenian: En odmerek po 0,5 ml vsebuje po 2 mikrograma saharidov serotipov 4, 9V, 14, 18C, 19F in 23F in 4 mikrograme serotipa 6B (vseh saharidov je 16 mikrogramov), konjugiranih na CRM197 nosilni protein in adsorbiranih na aluminijev fosfat (0,5 mg).
English: The preferred sites are anterolateral aspect of the thigh (vastus lateralis muscle) in infants or the deltoid muscle of the upper arm in young children.
Slovenian: Najprimernejše mesto injiciranja je anterolateralni del stegna (mišica vastus lateralis) pri dojenčkih ali deltoidna mišica na nadlahti pri majhnih otrocih.
English: Children below 2 years old should receive the appropriate-for-age Prevenar vaccination series (see section 4.2).
Slovenian: Pri otrocih, mlajših od 2 let, je treba uporabiti starosti primerno zaporedje cepljenj s cepivom Prevenar (glejte poglavje 4.2).
English: Fever of > 39 °C was reported in 3.3 % of children compared to 1.2 % in the control group.
Slovenian: O zvišani telesni temperaturi  39 °C so poročali pri 3,3 % otrok v primerjavi z 1,2 % otrok iz kontrolne skupine.
English: Do not use Prevenar after the expiry date stated on the carton and label.
Slovenian: Cepiva Prevenar ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
English: Vaccination in high-risk groups should be considered on an individual basis.
Slovenian: Glede cepljenja otrok z visokim tveganjem se je potrebno odločiti za vsakega posameznika posebej.
English: In European children between 2 to 5 years of age, Prevenar should cover about 62 % to 83 % of the clinical isolates responsible for invasive pneumococcal disease.
Slovenian: Pri evropskih otrocih, starih od 2 do 5 let, naj bi cepivo Prevenar pokrilo okrog 62 % do 83 % klinično izoliranih pnevmokokov, ki povzročajo invazivne pnevmokokne bolezni.
English: Children were vaccinated with Prevenar (3 doses one month apart from the age of 2 months) and 46 of these children also received a 23-valent pneumococcal polysaccharide vaccine at the age of 15-18 months.
Slovenian: Otroke so cepili s cepivom Prevenar (3 odmerki z enomesečnim presledkom od starosti 2 mesecev naprej), 46 od teh otrok pa so v starosti 15-18 mesecev cepili tudi s 23-valentnim polisaharidnim cepivom proti pnevmokokom.
English: If you forget to go back to the doctor or nurse at the scheduled time, ask the doctor or nurse for advice.
Slovenian: Če pozabite pripeljati otroka na cepljenje ob predpisanem času, se posvetujte z zdravnikom ali s
English: Most of the data have indicated that smaller proportions of infants achieved antibody concentrations ≥0.35 μg/ml (the reference antibody concentration recommended by
Slovenian: Podatki so večinoma pokazali, da je po primarnem zaporedju dveh odmerkov manjši del dojenčkov dosegel koncentracijo protiteles  0,35 µg/ml (referenčna koncentracija protiteles, ki jo priporoča SZO)
English: If this applies to your child, then the vaccination will be postponed until your child is feeling better.
Slovenian: V tem primeru bo zdravnik cepljenje odložil, dokler otrok ne bo ozdravel.
English: SCIENTIFIC CONCLUSIONS AND GROUNDS FOR VARIATION TO THE TERMS OF THE
Slovenian: ZNANSTVENI ZAKLJUČKI IN PODLAGA ZA SPREMEMBO POGOJEV DOVOLJENJA
English: A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. IZDELOVALCI BIOLOŠKIH ZDRAVILNIH UČINKOVIN IN IMETNIK DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVOREN ZA SPROŠČANJE SERIJE
English: Prevenar is a pneumococcal vaccine.
Slovenian: Prevenar je pnevmokokno cepivo.
English: Important information about some of the ingredients of Prevenar: This medicinal product contains less than 1 mmol sodium (23mg) per dose, i.e. essentially sodium-free.
Slovenian: Pomembne informacije o nekaterih sestavinah cepiva Prevenar: To cepivo vsebuje manj kot 1 mmol natrija (23 mg) na odmerke, kar v bistvu pomeni 'brez natrija'.
English: In the per-protocol analysis, the estimated risk reduction for the first episode of clinical pneumonia with abnormal chest radiograph (defined as the presence of infiltrates, effusion or consolidation) was 35 % (95 % CI: 4, 56).
Slovenian: V analizi skladno s protokolom cepljenja je bilo ocenjeno zmanjšanje tveganja za prvi izbruh klinične pljučnice z nenormalno rentgensko sliko prsnega koša (opredeljeno kot prisotnost infiltratov, izliv ali konsolidacija) 35 % (95-odstotni interval zaupanja: 4, 56).
English: Prevenar can be given at the same time as other childhood vaccines; in this case different injection sites
Slovenian: Otrok lahko dobi cepivo Prevenar skupaj z drugimi cepivi za otroke; v tem primeru bo zdravnik izbral različna mesta injiciranja.
English: A fourth dose is recommended in the second year of life.
Slovenian: Četrti odmerek je priporočljivo dati v drugem letu življenja.
English: Different injectable vaccines should always be given at different
Slovenian: Različna parenteralna cepiva je treba vedno dati na različnih mestih.
English: More than 37,816 infants were immunised with either Prevenar or a control vaccine (meningococcal conjugate group C vaccine), at 2, 4, 6 and 12-15 months of age.
Slovenian: Več kot 37.816 dojenčkov je bilo cepljenih ali s cepivom Prevenar ali s kontrolnim cepivom (konjugirano meningokokno C cepivo) v 2., 4., 6. in 12. do 15. mesecu življenja.
English: Prevenar is for intramuscular use only.
Slovenian: Cepivo Prevenar je namenjeno samo za intramuskularno uporabo.
English: The interval between the pneumococcal conjugate vaccine (Prevenar) and the 23valent pneumococcal polysaccharide vaccine should not be less than 8 weeks.
Slovenian: Presledek med konjugiranim pnevmokoknim cepivom (Prevenar) in 23-valentnim pnevmokoknim polisaharidnim cepivom mora biti najmanj 8 tednov.
English: 1 vial with syringe and 2 needles (1 for withdrawal, 1 for injection).
Slovenian: 1 viala z 1 brizgo in 2 iglama (1 za odvzem, 1 za injiciranje).
English: In addition, GMCs were lower for antibodies to most serotypes after a twodose infant series than after a three-dose infant series.
Slovenian: Poleg tega so bile po seriji dveh odmerkov za dojenčke vrednosti GMC nižje za protitelesa proti večini serotipov kot po seriji treh odmerkov za dojenčke.
English: • The first injection may be given from 2 months of age
Slovenian: • Prvi odmerek lahko prejme od starosti šestih tednov naprej.
English: A higher rate of local reactions has been observed in children older than 24 months of age compared with infants (see section 4.8).
Slovenian: Pri otrocih, starejših od 24 mesecev, so opažali večjo pogostnost lokalnih reakcij kot pri dojenčkih (glejte poglavje 4.8).
English: HOW PREVENAR IS GIVEN
Slovenian: KAKO SE CEPIVO PREVENAR UPORABLJA
English: The antibody response to Hib tetanus protein conjugate (PRP-T), tetanus and Hepatitis B (HepB) vaccines was similar to controls.
Slovenian: Porast protiteles po cepljenju s konjugiranim cepivom proti bakteriji Haemophilus influenzae tipa B (Hib), vezanim na tetanusni protein (PRP-T), cepivom proti tetanusu in cepivom proti hepatitisu B (HepB) je bil podoben kot v kontrolnih skupinah.
English: Ask your pharmacist how to dispose of medicines no longer required.
Slovenian: O načinu odstranjevanja cepiva, ki ga ne potrebujete več, se posvetujte s farmacevtom.
English: Amongst the most commonly reported adverse reactions were injection site reactions and fever.
Slovenian: Med najpogostejšimi neželenimi učinki so bile reakcije na mestu cepljenja in zvišana telesna
English: Alternatively, when Prevenar is given as part of a routine infant immunisation programme, a two-dose schedule may be considered.
Slovenian: Kadar se cepivo Prevenar daje v okviru rutinskega programa cepljenja dojenčkov, lahko pride v poštev tudi shema z dvema odmerkoma.
English: The other ingredients are sodium chloride and water for injections.
Slovenian: Pomožni snovi sta natrijev klorid in voda za injekcije.
English: The vaccine serotype coverage in the paediatric population decreases with increasing age.
Slovenian: Pokritje serotipov v cepivu se pri otrocih s starostjo zmanjšuje.
English: When Prevenar is co-administered with hexavalent vaccines (DTaP/Hib(PRP-T)/IPV/HepB), fever ≥ 38 °C per dose was reported in 28.3 % to 48.3 % of infants in the group receiving Prevenar and the hexavalent vaccine at the same time as compared to 15.6 % to 23.4 % in the group receiving the hexavalent vaccine alone.
Slovenian: Če so Prevenar kombinirali s šestvalentnimi cepivi (DTaP/Hib(PRP-T)IPV/HepB), se je zvišana telesna temperatura  38 °C po enem odmerku pojavila pri 28,3 % do 48,3 % dojenčkov, medtem ko se je pri dojenčkih, ki so prejemali samo šestvalentno cepivo, ta pojavila samo pri 15,6 % do 23,4 %.
English: Redness was reported in 40.0 % of children, and induration was reported in 32.2 % of subjects.
Slovenian: Pordelost so zabeležili pri 40,0 % otrok, zatrdlino pa pri 32,2 %.
English: Children below 2 years old (including those at high-risk) should receive the appropriate-for-age Prevenar vaccination series.
Slovenian: Pri otrocih, mlajših od 2 let (vključno z zelo ogroženimi), je treba uporabiti starosti primerno zaporedje cepljenj s cepivom Prevenar.
English: Clinical trial efficacy of the two-dose infant primary series plus a booster has not been established, and the clinical consequences of lower antibody concentrations against serotypes 6B and 23F after the two-dose
Slovenian: Učinkovitosti primarne serije za dojenčke z dvema odmerkoma in poživitvenim odmerkom niso dokazali in klinične posledice nižjih koncentracij protiteles proti serotipoma 6B in 23F po zaporedju za dojenčke z dvema odmerkoma niso znane.
English: Uncommon side effects (these may occur with up to 1 in 100 doses of the vaccine) are: • Rash/hives (urticaria)
Slovenian: Občasni neželeni učinki (lahko se pojavijo pri največ 1 od 100 odmerkov cepiva) so: • izpuščaj/koprivnica (urtikarija)
English: Therefore, in view of available data the PRAC considered that changes to the conditions of the marketing
Slovenian: Odbor PRAC na podlagi razpoložljivih podatkov priporoča spremembo pogojev dovoljenja za promet z zdravilom.
English: A significant increase was seen in the concentrations of antibodies against the seven serotypes after the polysaccharide vaccination, suggesting that immunological memory was well established.
Slovenian: Koncentracije protiteles proti sedmim serotipom so se po cepljenju s polisaharidnim cepivom signifikantno zvišale, kar kaže na to, da je bil imunološki spomin že dobro vzpostavljen.
English: Bacteria can be responsible for 60-70% of clinical episodes of AOM.
Slovenian: Bakterije utegnejo zakriviti 60 % - 70 % kliničnih izbruhov AOM.
English: Pfizer AS Tlf: +47 67 526 100
Slovenian: Tlf: +47 67 526 100
English: Significant increases in antibody (measured by ELISA) were seen for all vaccine serotypes following a three-dose primary series of Prevenar in infants and following booster doses although geometric mean concentrations varied between the 7 serotypes.
Slovenian: Znaten porast protiteles (izmerjen z ELISA) so ugotovili za vse serotipe, vključene v cepivo, po primarnem zaporedju treh odmerkov cepiva Prevenar pri dojenčkih in po poživitvenih odmerkih, čeprav so bile geometrične srednje koncentracije (GMC) 7-ih serotipov različne.
English: Efficacy of Prevenar against acute otitis media (AOM) was assessed in a randomised, double blind, clinical trial of 1,662 Finnish infants immunised with either Prevenar or a control vaccine (Hepatitis B vaccine), at 2, 4, 6 and 12-15 months of age.
Slovenian: Učinkovitost cepiva Prevenar pri preprečevanju akutnega vnetja srednjega ušesa (AOM) so preučevali v randomizirani dvojno slepi klinični študiji na 1.662 finskih dojenčkih, cepljenih bodisi s cepivom Prevenar bodisi s kontrolnim cepivom (cepivo proti hepatitisu B) v starosti 2, 4, 6 in 12-15 mesecev.
English: Children aged 24 months - 5 years: one single dose.
Slovenian: Otroci, stari od 24 mesecev do 5 let: en sam odmerek.
English: In the USA in the same time frame, there was a 94% reduction in vaccine type IPD in individuals under 5 years of age, compared to a pre-vaccine baseline (1998/99).
Slovenian: V ZDA so se v istem časovnem okviru IPD, povzročene s serotipi, ki so vključeni v cepivo, pri otrocih, mlajših od 5 let, v primerjavi z izhodiščem pred cepljenjem (1998/99) zmanjšale za 94 %.
English: The vaccine should be well shaken to obtain a homogeneous white suspension and be inspected visually for any particulate matter and/or variation of physical aspect prior to administration.
Slovenian: Cepivo je treba pred uporabo dobro pretresti, da nastane bela homogena suspenzija, in ga pred uporabo dobro pregledati, da ne vsebuje delcev in/ali ni drugačnega fizikalnega videza.
English: Limited data have demonstrated that Prevenar (three dose primary series) induces an acceptable immune response in infants with sickle cell disease with a safety profile similar to that observed in non-high-risk groups (see section 5.1).
Slovenian: Obstaja nekaj podatkov, ki so pokazali, da Prevenar (primarno zaporedje treh odmerkov) pri dojenčkih z anemijo srpastih celic sproži sprejemljiv imunski odziv s podobnim varnostnim profilom kot pri skupinah, pri katerih tveganje ni veliko (glejte poglavje 5.1).
English: Efficacy of Prevenar against AOM was assessed as a secondary endpoint in the Kaiser Permanente trial.
Slovenian: Učinkovitost cepiva Prevenar proti akutnemu vnetju srednjega ušesa so ocenili kot sekundarni cilj učinkovitosti v študiji Kaiser Permanente.
English: urticaria or urticaria-like rash (hives)
Slovenian: koprivnica (urtikarija) ali srbenje
English: In a clinical trial that compared separate with concomitant administrations of Prevenar (three doses at 2, 3.5, 6 months and a booster dose at approximately 12 months) and Meningitec (meningococcal C conjugate vaccine; two doses at 2 and 6 months and a booster dose at approximately 12 months) there was no evidence of immune interference between the two conjugate vaccines after the primary series or after
Slovenian: V kliničnem preskušanju, ki je primerjalo samostojno uporabo cepiva Prevenar (trije odmerki pri 2, 3,5 in 6 mesecih ter poživitveni odmerek pri približno 12 mesecih starosti) in sočasno uporabo tega cepiva s cepivom Meningitec (konjugirano meningokokno C cepivo; 2 odmerka pri 2 in 6 mesecih in poživitveni odmerek pri približno 12 mesecih starosti), niso pokazali motečega imunskega vpliva v primarnih serijah ali po poživitvenem cepljenju ob sočasnem dajanju obeh cepiv.
English: Fever of greater than 39.5 °C per dose was observed in 0.6 to 2.8 % of infants receiving Prevenar and hexavalent vaccines (see section 4.4).
Slovenian: Telesno temperaturo  39,5 °C po enem odmerku so opazili pri 0,6 % do 2,8 % dojenčkov, ki so prejemali Prevenar in šestvalentno cepivo istočasno (glejte poglavje 4.4).
English: Administration of unconjugated pneumococcal polysaccharides at 13 months following the primary series with Prevenar elicited an anamnestic antibody response for the 7 serotypes included in the vaccine, indicating
Slovenian: Dajanje nekonjugiranih pnevmokoknih polisaharidov pri 13 mesecih po primarnem zaporedju cepljenja s cepivom Prevenar je izzvalo spominski protitelesni odziv na vseh 7 v cepivo vključenih serotipov, kar kaže, da je bilo prvo
English: This indirect or herd effect is due to a reduction in transmission of vaccine serotypes from immunised young children to the rest of the population and coincides with decreased nasopharyngeal carriage of vaccine serotypes.
Slovenian: Ta posredni ali skupinski učinek je posledica manjšega prenašanja serotipov, vključenih v cepivo, s cepljenih mlajših otrok na preostalo populacijo in sovpada z zmanjšanim prenašanjem serotipov, vključenih v cepivo, v nazofarinksu.
English: In Europe, the estimates of effectiveness in children less than 2 years of age range from 51 % to 79 % when considering vaccine coverage against serotypes causing invasive disease.
Slovenian: V Evropi se ocena učinkovitosti pri otrocih, mlajših od 2 let, giblje med 51 % in 79 %, če upoštevamo tudi pokritost serotipov, ki povzročajo IPD, s cepivom.
English: After primary immunisation, 95.6% of the subjects had antibody levels of at least 0.35 µg/ml for all seven serotypes found in Prevenar.
Slovenian: Po primarni imunizaciji je bila koncentracija protiteles pri 95,6 % preiskovancev za vseh sedem serotipov, prisotnih v cepivu Prevenar, vsaj 0,35 µg/ml.
English: Hypersensitivity to the active substances or to any of the excipients, or to diphtheria toxoid.
Slovenian: Preobčutljivost na zdravilne učinkovine, katerokoli pomožno snov cepiva ali za davični toksoid.
English: 2 against serotypes 6B and 23F after two-dose primary series when directly or indirectly compared with three-dose primary series.
Slovenian: 2 proti serotipoma 6B in 23F, če to neposredno ali posredno primerjamo s primarnim zaporedjem treh odmerkov.
English: Active immunisation against disease caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F and 23F (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media) in infants and children from 2 months up to 5 years of age (see sections 4.2, 4.4 and 5.1).
Slovenian: Aktivna imunizacija proti boleznim, ki jih povzroča Streptococcus pneumoniae serotipov 4, 6B, 9V, 14, 18C, 19F in 23F (vključno s sepso, meningitisom, pljučnico, bakteriemijo in akutnim vnetjem srednjega ušesa) pri dojenčkih in otrocih od 2. meseca do 5. leta starosti (glejte poglavja 4.2, 4.4
English: 1 against serotypes 6B and 23F after two-dose primary series when directly or indirectly compared with three-dose primary series.
Slovenian: 1 proti serotipoma 6B in 23F, če to neposredno ali posredno primerjamo s primarnim zaporedjem treh odmerkov.
English: In a study, including 1,662 children, fever of  38 °C was reported in 41.2 % of children who received Prevenar simultaneously with DTP as compared to 27.9 % in the control group.
Slovenian: V študiji pri 1.662 otrocih, ki so skupaj s cepivom Prevenar prejeli tudi cepivo DTP, so poročali o zvišani telesni temperaturi  38 °C pri 41,2 % otrok; v kontrolni skupini pa samo pri 27,9 %.
English: Pack size of 1 vial with syringe and 2 needles (1 for withdrawal, 1 for injection).
Slovenian: Pakiranje s po 1 vialo z brizgo in 2 iglama (1 za odvzem, 1 za injiciranje).
English: In the first two years of the programme, with over 90% coverage, the observed effectiveness against IPD caused by vaccine serotypes was 93% (95% CI 75-98) for the 2 dose infant series and 100% (95% CI 91-100) for the completed schedule.
Slovenian: V prvih dveh letih programa z več kot 90odstotno pokritostjo je bila ugotovljena učinkovitost proti IPD, povzročenim s serotipi, vključenimi v cepivo, 93 % (95-odstotni interval zaupanja 75-98) pri zaporedju za dojenčke z 2 odmerkoma in 100 % (95-odstotni interval zaupanja 91-100) pri dokončanem programu.
English: However, antibody responses to booster doses in toddlers following two-dose or three-dose infant series were comparable for all 7 vaccine serotypes and indicated that both infant regimens had elicited adequate priming.
Slovenian: So pa bili odzivi protiteles na poživitvene odmerke pri malih otrocih po zaporedju dveh odmerkov ali treh odmerkov za dojenčke podobni pri vseh 7-ih v cepivo vključenih serotipih, kar kaže, da sta obe shemi za dojenčke izzvali ustrezno reakcijo na prvo cepljenje.
English: There have been reports of overdose with Prevenar, including cases of administration of a higher than recommended dose and cases of subsequent doses administered closer than recommended to the previous dose.
Slovenian: Obstajajo poročila o prevelikem odmerjanju cepiva Prevenar, in sicer vključno s poročili o večjem odmerku od priporočenega in poročila o aplikaciji cepiva po krajšem presledku od priporočenega.
English: Prevenar has also been shown to elicit functional antibodies (measured by opsonophagocytosis) to all vaccine serotypes following the primary series.
Slovenian: Dokazali so tudi, da Prevenar po primarnem zaporedju spodbuja funkcionalna protitelesa (merjena z opsonofagocitozo) proti vsem v cepivo vključenim serotipom.
English: The immune response to routine paediatric vaccines co-administered with Prevenar at different injection sites was assessed in 7 controlled clinical studies.
Slovenian: Imunski odgovor na običajna otroška cepiva, ki se dajejo istočasno s cepivom Prevenar na različna mesta, so proučevali v 7 kontroliranih kliničnih študijah.
English: Sufficient data regarding interference on the concomitant administration of other hexavalent vaccines with Prevenar are currently not available.
Slovenian: Zadostnih podatkov o interakcijah cepiva Prevenar z drugimi šestvalentnimi cepivi še ni.